FDA to approve Omicron bivalent boosters this week.
The WSJ is reporting that the FDA is expected to approve the Omicron-specific bivalent coronavirus boosters this week. Shots in arms potentially as soon as Labor Day.
The WSJ article frames it like the FDA is only relying on animal data, but that isn't very accurate. The FDA has human data for previous Omicron sub-variant BA.1 bivalent vaccines from both Moderna and Pfizer. We are only lacking human data for the BA.5 vaccines.
And as Califf notes here, we have significant real world safety data for the previous coronavirus vaccines. They are extremely safe. Updating the vaccines isn't expected to change that strong safety profile. This is how the influenza vaccine is updated each season to target the expected influenza strains.
VRBPAC will not meet before the FDA approval.
Leave FDA to approve Omicron bivalent boosters this week. to:
Best Posts From zafrada
We have not curated any of zafrada's posts yet. But you can encourage our curation team to review posts by visiting them regularly and by referring other readers. Because we give priority to frequently read content.
More Posts From zafrada
- FDA approves lecanemab under its accelerated approval.
- Going to 12 rounds. Only 4 speakership votes have gone on longer than this in the entire history of the House.
- The militarization of American society since WW2.
- GDPNow still not calling for recession.
- Omicron sub-varian XBB.1.5 becomes dominant strain.
- One small change with potentially big consequences.
- Millennials are not getting more conservative as they age.
- Pros and cons of capitalism and maybe some new definitions.
- So far, no new variants have emerged from China.
- This dude is tiresome.